The Futorque® X-1 is a cutting-edge, hybrid, R&D tablet press that is also the most flexible, user friendly and compact tablet press produced by kg-pharma. With its “operation-by-process” control software, tablet development becomes as easy as using a smartphone. Impressive output capabilities of up to 129,600 tablets/h and a footprint of less than 0.8 sqm (10.8 sqf) offer the maximum efficiency in a compact form.
Versatile tablet batch production
KG Pharma’s Futorque® X-1 offers a hybrid rotary tablet press that sets new standards worldwide for tablet development purposes. The system performance pays off from the preparation of clinical studies and orphan drugs all the way to small scale commercial launch batches, thanks to the use of Futorque® X-1, no major production machine has to be stopped and a high tablet output is achieved.
Intuitive software for tablet development
The operation software sets new standards in design and intuitive operation. A huge 18.5″ BECKHOFF multi-touch display, complete with an all new control software, simplifies tablet development significantly. The state-of-the-art EtherCAT operation and monitoring technology makes the Futorque® X-1 the most advanced R&D tablet press on the market.
Adaptive turret options for flexible tabletting R&D
The Futorque® X-1 offers, as one of many other technical innovations, a high torque servo drive for maximum force at slow turret speed, often required in tabletting R&D. The product name chosen for the range has been coined from a combination of the words ‘future’ and ‘torque’. The designation X-1 offers the prospect that after the first model – for mono-layer tablets – further models will follow. The standard turrets B-18 and D-14, the combi-system and the FlexAdapt X-14 system offer a pitch circle of 240 mm.
